A new technology developed by scientists combines small molecule screening methods with machine learning algorithms to identify novel antibiotics that inhibit ribosomes.
List view / Grid view
Filter the results
A study in mice has found that a compound modelled on a protein found in bananas safely protects against multiple strains of the influenza virus.
In an effort to address some of the more serious untreatable infections encountered by patients with cystic fibrosis, Calibr will collaborate with the Cystic Fibrosis Foundation on a two-year project.
A study has shown that the SVC112 molecule can prevent cancer stem cells from producing more tumour cells in cell lines and mice, with no impact on healthy cells.
This article highlights some of the most recent drug target discoveries that could be used to develop and design a treatment for pancreatic cancer.
The ICR has revealed that during drug discovery, researchers should not use general search engines and vendor catalogue information to decide on their use of chemical probes.
A compound that has antimicrobial properties has been found by researchers, which could be used to combat drug-resistant infections.
A world-first compound that can keep cells alive and functioning in a healthy state could be revolutionary for medical emergencies.
The memory of mice with Alzheimer's greatly improved after they were injected with two newly discovered short peptides.
Chronic inflammatory processes in ageing brains lead to lymphoma cells that have entered the brain tissue being retained.
A new platform has enabled an unprecedented level of control over individual molecules and particles on a chip for high-throughput analysis.
A new study has found a small molecule which prevents cancer cells from mutating and becoming resistant to chemotherapy.
Small molecule drug discovery has long been the domain of pharmaceutical companies, and that’s not likely to change anytime soon. But there’s a cadre of universities and nonprofit research institutes that have embraced drug development at its earliest stages, in some cases identifying and optimising compounds that target possible disease-driving…